Stocks-VRDN-Viridian Therapeutics Inc

VRDN Viridian Therapeutics Inc

22.90 0.30 (1.31%)
in USD Market Open
Invest
Invest

Overview

Prev Close22.61
Day's Range 22.49 - 23.07
52 Week Range 9.42 - 26.11
Average Volume (3m)477.81K
1-Year Return27.47%
Beta0.8074
Market Cap910.01M
P/E Ratio
Revenue1.88M
EPS-4.2116
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Chart times in UTC
Industry Pharmaceuticals Major
CEO Jonathan Violin, PhD, MBA
Employees 50

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Viridian Therapeutics Inc's revenues increased by 182.19% and amounted to 2.96M. Net income increased by 28.27% to -79.41M. Net assets decreased by NaN to N/A and EPS increased from -31.13 to -6.66.
VRDN's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
N/A
Net Profit Margin
-3,043.10%
Operating Margin
-11,036.69%
Return On Investment
-90.55%
12/21
03/22
06/22
09/22
Total Revenue
214K
216K
256K
1.2M
Gross Profit
N/A
N/A
N/A
N/A
Operating Income
-29.08M
-25.89M
-29.56M
-29.79M
Net Income
-28.95M
-25.69M
-29.49M
-28.91M